Pierre C, Lecossier D, Boussougant Y, Bocart D, Joly V, Yeni P, Hance A J
Institut National de la Santé et de la Recherche Médicale U.82, Faculté de Médecine Xavier Bichat, Paris, France.
J Clin Microbiol. 1991 Apr;29(4):712-7. doi: 10.1128/jcm.29.4.712-717.1991.
We have compared the sensitivity and specificity of quantitative mycobacterial culture against results obtained by using the polymerase chain reaction for the detection of DNA from organisms of the Mycobacterium tuberculosis complex in 82 clinical specimens from patients suspected of having tuberculosis. Two amplification protocols were used, a standard amplification protocol, which amplifies a segment of the gene coding for the 65-kDa antigen, and a protocol in which the initial amplification products are reamplified with a second set of nested oligonucleotide primers. Although the standard amplification protocol gave positive results for 18 of 18 samples which grew greater than 100 CFU/ml and gave positive results in 4 of 35 specimens from patients with tuberculosis which were negative by culture, only 1 of 6 samples which grew less than 100 CFU/ml was positive. This lack of sensitivity could not be explained by the presence of inhibitors of Taq polymerase present in the original samples. In contrast, the reamplification protocol gave positive results for 24 of 24 samples which were positive by culture as well as for 13 of 35 samples from patients with tuberculosis which were negative by culture (overall sensitivity, 63%, P less than 0.02, compared with the standard amplification protocol and routine culture). Two of 23 samples from patients not diagnosed as having tuberculosis gave positive results when the standard amplification protocol was used, but no additional false-positive results were seen with the reamplification protocol (overall specificity, 91%). We conclude that the use of a reamplification protocol improves the sensitivity of detection of mycobacterial DNA in clinical samples without sacrificing specificity. The sensitivity of this approach appears to be superior to that of standard culture techniques.
我们比较了定量分枝杆菌培养法与聚合酶链反应检测结核分枝杆菌复合群生物体DNA的结果,这些结果来自82份疑似患有结核病患者的临床标本。使用了两种扩增方案,一种是标准扩增方案,扩增编码65 kDa抗原的基因片段,另一种方案是用第二组巢式寡核苷酸引物对初始扩增产物进行再扩增。虽然标准扩增方案对18份每毫升生长超过100 CFU的样本中的18份给出了阳性结果,并且对35份结核病患者培养阴性的标本中的4份给出了阳性结果,但在6份每毫升生长低于100 CFU的样本中只有1份呈阳性。原始样本中存在的Taq聚合酶抑制剂无法解释这种敏感性的缺乏。相比之下,再扩增方案对24份培养阳性的样本中的24份以及35份结核病患者培养阴性的样本中的13份给出了阳性结果(总体敏感性为63%,与标准扩增方案和常规培养相比,P小于0.02)。使用标准扩增方案时,23份未诊断为患有结核病患者的样本中有2份给出了阳性结果,但再扩增方案未出现额外的假阳性结果(总体特异性为91%)。我们得出结论,使用再扩增方案可提高临床样本中分枝杆菌DNA检测的敏感性,而不牺牲特异性。这种方法的敏感性似乎优于标准培养技术。